Luis Belo Selected Research

3,4-dihydroxyphenylethanol-elenolic acid dialdehyde

1/2010

Powerful protective role of 3,4-dihydroxyphenylethanol-elenolic acid dialdehyde against erythrocyte oxidative-induced hemolysis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Luis Belo Research Topics

Disease

2	Hemolysis 07/2013 - 01/2010
2	Pre-Eclampsia (Preeclampsia) 01/2010 - 01/2008
1	Overweight 01/2016
1	Insulin Resistance 01/2016
1	Obesity 01/2016
1	Infections 01/2011
1	Chronic Kidney Failure (Chronic Renal Failure) 01/2011
1	Lymphopenia (Lymphocytopenia) 01/2011
1	Cardiovascular Diseases (Cardiovascular Disease) 01/2010
1	Birth Weight (Birth Weights) 01/2010
1	Hyperlipidemias (Hyperlipidemia) 01/2008

Drug/Important Bio-Agent (IBA)

3	LipidsIBA 01/2016 - 01/2008
2	3,4-dihydroxyphenylethanol (hydroxytyrosol)IBA 07/2013 - 01/2010
1	AdiponectinIBA 01/2016
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2016
1	AdipokinesIBA 01/2016
1	GlucuronidesIBA 07/2013
1	Acetates (Acetic Acid Esters)FDA Link 07/2013
1	2,2'-azobis(2-amidinopropane) (ABAP)IBA 07/2013
1	3,4-dihydroxyphenylethanol-elenolic acid dialdehydeIBA 01/2010
1	oleuropeinIBA 01/2010
1	AcidsIBA 01/2010
1	Olive OilIBA 01/2010
1	oxidized low density lipoproteinIBA 01/2010
1	Lipoproteins (Lipoprotein)IBA 01/2008

Therapy/Procedure

1	Renal Dialysis (Hemodialysis) 01/2011
1	Therapeutics 01/2011
1	Cesarean Section (Caesarean Section) 01/2010